These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 22647889

  • 1. Hypertension in aortic stenosis: implications for left ventricular structure and cardiovascular events.
    Rieck ÅE, Cramariuc D, Boman K, Gohlke-Bärwolf C, Staal EM, Lønnebakken MT, Rossebø AB, Gerdts E.
    Hypertension; 2012 Jul; 60(1):90-7. PubMed ID: 22647889
    [Abstract] [Full Text] [Related]

  • 2. Relation of Left Ventricular Mass to Prognosis in Initially Asymptomatic Mild to Moderate Aortic Valve Stenosis.
    Gerdts E, Rossebø AB, Pedersen TR, Cioffi G, Lønnebakken MT, Cramariuc D, Rogge BP, Devereux RB.
    Circ Cardiovasc Imaging; 2015 Nov; 8(11):e003644; discussion e003644. PubMed ID: 26489804
    [Abstract] [Full Text] [Related]

  • 3. Effect of obesity on left ventricular mass and systolic function in patients with asymptomatic aortic stenosis (a Simvastatin Ezetimibe in Aortic Stenosis [SEAS] substudy).
    Lund BP, Gohlke-Bärwolf C, Cramariuc D, Rossebø AB, Rieck AE, Gerdts E.
    Am J Cardiol; 2010 May 15; 105(10):1456-60. PubMed ID: 20451694
    [Abstract] [Full Text] [Related]

  • 4. Impact of hypertension on left ventricular structure in patients with asymptomatic aortic valve stenosis (a SEAS substudy).
    Rieck AE, Cramariuc D, Staal EM, Rossebø AB, Wachtell K, Gerdts E.
    J Hypertens; 2010 Feb 15; 28(2):377-83. PubMed ID: 19844185
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
    Greve AM, Boman K, Gohlke-Baerwolf C, Kesäniemi YA, Nienaber C, Ray S, Egstrup K, Rossebø AB, Devereux RB, Køber L, Willenheimer R, Wachtell K.
    Circulation; 2012 Jan 17; 125(2):346-53. PubMed ID: 22147903
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of lipid lowering on new-onset atrial fibrillation in patients with asymptomatic aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) study.
    Bang CN, Greve AM, Boman K, Egstrup K, Gohlke-Baerwolf C, Køber L, Nienaber CA, Ray S, Rossebø AB, Wachtell K.
    Am Heart J; 2012 Apr 17; 163(4):690-6. PubMed ID: 22520536
    [Abstract] [Full Text] [Related]

  • 12. Global left ventricular load in asymptomatic aortic stenosis: covariates and prognostic implication (the SEAS trial).
    Rieck AE, Gerdts E, Lønnebakken MT, Bahlmann E, Cioffi G, Gohlke-Bärwolf C, Ray S, Cramariuc D.
    Cardiovasc Ultrasound; 2012 Nov 05; 10():43. PubMed ID: 23126645
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Left atrial size and function as predictors of new-onset of atrial fibrillation in patients with asymptomatic aortic stenosis: the simvastatin and ezetimibe in aortic stenosis study.
    Bang CN, Dalsgaard M, Greve AM, Køber L, Gohlke-Baerwolf C, Ray S, Rossebø AB, Egstrup K, Wachtell K.
    Int J Cardiol; 2013 Oct 03; 168(3):2322-7. PubMed ID: 23416018
    [Abstract] [Full Text] [Related]

  • 15. Factors influencing left ventricular structure and stress-corrected systolic function in men and women with asymptomatic aortic valve stenosis (a SEAS Substudy).
    Cramariuc D, Rieck AE, Staal EM, Wachtell K, Eriksen E, Rossebø AB, Gerdts E.
    Am J Cardiol; 2008 Feb 15; 101(4):510-5. PubMed ID: 18312768
    [Abstract] [Full Text] [Related]

  • 16. Impact of baseline severity of aortic valve stenosis on effect of intensive lipid lowering therapy (from the SEAS study).
    Gerdts E, Rossebø AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, Gohlke-Bärwolf C, Holme I, Kesäniemi YA, Malbecq W, Nienaber C, Ray S, Skjærpe T, Wachtell K, Willenheimer R.
    Am J Cardiol; 2010 Dec 01; 106(11):1634-9. PubMed ID: 21094366
    [Abstract] [Full Text] [Related]

  • 17. Resting heart rate and risk of adverse cardiovascular outcomes in asymptomatic aortic stenosis: the SEAS study.
    Greve AM, Bang CN, Berg RM, Egstrup K, Rossebø AB, Boman K, Nienaber CA, Ray S, Gohlke-Baerwolf C, Nielsen OW, Okin PM, Devereux RB, Køber L, Wachtell K.
    Int J Cardiol; 2015 Feb 01; 180():122-8. PubMed ID: 25438232
    [Abstract] [Full Text] [Related]

  • 18. Usefulness of the electrocardiogram in predicting cardiovascular mortality in asymptomatic adults with aortic stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis Study).
    Greve AM, Dalsgaard M, Bang CN, Egstrup K, Rossebø AB, Boman K, Cramariuc D, Nienaber CA, Ray S, Gohlke-Baerwolf C, Okin PM, Devereux RB, Køber L, Wachtell K.
    Am J Cardiol; 2014 Sep 01; 114(5):751-6. PubMed ID: 25048345
    [Abstract] [Full Text] [Related]

  • 19. Asymmetric septal hypertrophy - a marker of hypertension in aortic stenosis (a SEAS substudy).
    Tuseth N, Cramariuc D, Rieck AE, Wachtell K, Gerdts E.
    Blood Press; 2010 Jun 01; 19(3):140-4. PubMed ID: 20429691
    [Abstract] [Full Text] [Related]

  • 20. Left atrial systolic force in asymptomatic aortic stenosis.
    Cioffi G, Cramariuc D, Dalsgaard M, Davidsen ES, Egstrup K, de Simone G, Gerdts E.
    Echocardiography; 2011 Oct 01; 28(9):968-77. PubMed ID: 21854438
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.